Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: Pivotal role for glia-neuron interactions

Brain Research Reviews

Volumn 48, Issue 2, 2005, Pages 302-321

  Marchetti, Bianca ^a,b   Serra, Pier Andrea ^b   Tirolo, Cataldo ^a   L'Episcopo, Francesca ^a   Caniglia, Salvo ^a   Gennuso, Florinda ^a   Testa, Nuccio ^a   Miele, Egidio ^b   Desole, Speranza ^b   Barden, Nicholas ^c   Morale, Maria Concetta ^a  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Glucocorticoid receptor; Inducible nitric oxide synthase; Neuroinflammation; Neuron glia interactions; Neuroprotection; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; COMPLEMENTARY RNA; GLUCOCORTICOID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NEUROTOXIN; NITRIC OXIDE;

CELL DEATH; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; EMBRYO; GENE EXPRESSION; GLIA CELL; HOMEOSTASIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; INNATE IMMUNITY; MACROGLIA; MACROPHAGE; MICROGLIA; MOUSE STRAIN; NERVE CELL LESION; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL; TRANSGENIC MOUSE; WILD TYPE;

EID: 20244369883     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.12.030     Document Type: Conference Paper

References (145)

1. I.M. Abraham, T. Harkany, K.M. Horvath, and P.G. Luiten Do glucocorticoids contribute to brain aging? J. Neuroendocrinol. 13 2001 749 760
2. E. Ahbon, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli Prenatal exposure to high levels of glucocorticoids increase the susceptibility of cerebellar granule cells to oxidative stress-induced cell death Proc. Natl. Acad. Sci. U. S. A. 97 2000 14726 14730
3. I. Allaman, L. Pellerin, and P. Magistretti Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes J. Neurochem. 88 2004 900 908
4. F. Aloisi Immune function of microglia Glia 36 2001 165 179
5. E. Araki, C. Forster, J.M. Dubinsky, M.E. Ross, and C. Iadecola Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity Stroke 32 2001 2370 2375
6. M. Asanuma, S. Nishibayashi-Asanuma, I. Miyazaki, M. Kohno, and N. Ogawa Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals J. Neurochem. 76 2001 1895 1904
7. N. Aubin, O. Curet, A. Deffois, and C. Carter Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice J. Neurochem. 71 1998 1635 1642
8. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmerg, and M. Karim Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 270 1995 286 290
9. A. Bal-Price, and G.C. Brown Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity J. Neurosci. 21 2001 6480 6491
10. R.B. Banati, J. Gehrmann, P. Schubert, and G.W. Kreutzberg Cytotoxicity of microglia Glia 7 1993 111 118
11. N. Barden Implications of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression J. Psychiatry Neurosci. 29 2004 185 193
12. N. Barden, I.S.M. Stec, A. Montkowski, F. Holsboer, and J.M.H.M. Reul Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense-RNA against the glucocorticoid receptor Neuroendocrinology 3 1997 212 220
13. P.J. Barnes, and I. Adcock Anti-inflammatory actions of steroids: molecular mechanisms Trends Pharmacol. Sci. 1993 436 441
14. F. Beal Experimental models of Parkinson's disease Nat. Rev. Neurosci. 2 2001 325 332
15. J.S. Beckman, J. Chen, H. Ischiropoulos, and J.P. Crow Oxidative chemistry of peroxynitrite Methods Enzymol. 233 1994 229 240
16. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
17. E. Bezard, M. Jaber, F. Gonon, A. Boireau, B. Bloch, and C.E. Gross Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse Eur. J. Neurosci. 12 2000 2892 2900
18. E. Bezard, S. Dovero, D. Belin, S. Duconger, V. Jackson-Lewis, S. Przedborski, V. Piazza, C.E. Gross, and M. Jaber Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors J. Neurosci. 23 2003 10999 11007
19. J.P. Bolanos, S.J.R. Heales, S. Peuchen, J.E. Barker, and J.B. Clark Nitric oxide-mediated mitochondrial damage: a potential role for glutathione Free Radic. Biol. Med. 21 1996 995 1001
20. C. Bogdan The multiplex function of nitric oxide in (auto)immunity J. Exp. Med. 187 1998 1361 1365
21. G.C. Brown, and V. Borutaite Nitric oxide, mitochondria and cell death IUBMB Life 52 2001 189 195 (Rev.)
22. C. Cadepond, C. Massaad, A. Trousson, J. Grenier, G. Groyer, E. Baulieu, and M. Schumacher Steroid receptors in various glial cell lines expression and functional studies Ann. N.Y. Acad. Sci. 973 2002 484 487
23. A. Castano, A.J. Herrera, J. Cano, and A. Machado The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alfa, I-1beta and IFN-gamma J. Neurochem. 81 2002 150 157
24. R.S. Chan, E.D. Huey, H.L. Maecker, K.M. Cortopassi, S.A. Howard, A.M. Iyer, L.J. McIntosh, O.A. Ajilore, S.M. Brooke, and R.M. Sapolsky Endocrine modulators of necrotic neuron death Brain Pathol. 6 1996 481 491
25. J.Y. Chang, and L.Z. Liu Inhibition of microglial nitric oxide production by hydrocortisone and glucocorticoid precursors Neurochem. Res. 7 2000 903 908
26. J.D. Cheng, and J. De Vellis Oligodendrocytes as glucocorticoids target cells: functional analysis of the glycerol phosphate dehydrogenase gene J. Neurosci. Res. 59 2000 436 445
27. K. Chiba, A. Trevor, and N. Castagnoli Jr. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes Biochem. Biophys. Res. Commun. 128 1985 1228 1232
28. J.J. Choi, Y.K. Oh, S. Kim, H.C. Kim, K.H. Ko, and W.K. Kim Mimosine prevents the death of glucose-deprived immunostimulated astrocytes by scavenging peroxynitrite Glia 39 2002 37 46
29. M. Colasanti The dual personality of NO Trends Pharmacol. Sci. 21 2000 249 252
30. G.P. Chrousos The stress response and immune function: clinical implications Ann. N.Y. Acad. Sci. 917 2000 38 67
31. F.F. Cruz-Sanchez, A. Cardozo, S. Ambrosio, E. Tolosa, and N. Mahy Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation Mol. Chem. Neuropathol. 19 1993 163 176
32. T. Dehmer, J. Lindenau, S. Haid, J. Dichgans, and J.B. Schulz Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo J. Neurochem. 74 2000 2213 2216
33. E.R. De Kloet Hormones, brain and stress Endocr. Regul. 37 2003 51 68
34. E.R. De Kloet, and J.M.H.M. Reul Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems PsychoNeuro Endocrinol. 12 1987 83 105
35. M.E. De Vera, B.S. Taylor, Q. Wang, R.A. Shapiro, T.R. Billiar, and D.A. Geller Dexamethazone suppresses iNOS gene expression by up-regulating I-kB? and inhibiting NF-KB AJP, Gastrointest. Liver Physiol. 273 1997 1290 1296
36. B. Dipasquale, M. Marini, and R.J. Youl Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons Biochem. Biophys. Res. Commun. 181 1991 1442 1448
37. P.D. Drew, and J.A. Chavis Inhibition of microglial cell activation by cortisol Brain Res. Bull. 52 2000 391 396
38. R. Dringen, and J. Hirrlinger Glutathione pathways in brain Biol. Chem. 384 2003 505 516
39. R. Dringen, J. Gutterer, and M.J. Hirrlinger Glutathione metabolism in brain. Metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species Eur. J. Biochem. 267 2000 4912 4916
40. Y. Du, Z. Ma, S. Lin, R.C. Dodel, F. Gao, K.R. Bales, L.C. Triarhou, E. Chernet, K.W. Perry, D.L. Nelson, S. Luecke, L.A. Phebus, F.P. Bymaster, and S.M. Paul Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 98 2001 14669 14674
41. C.D. Ekdal, J.H. Claasen, S. Bonde, Z. Kokaia, and O. Lindvall Inflammation is detrimental for neurogenesis in adult brain Proc. Natl. Acad. Sci. U. S. A. 100 2003 13632 13637
42. C.E. Finch Stress mechanisms and the age-related increase in GFAP transcription in brain astrocytes Dev. Brain Dysfunct. 10 1997 350 358
43. M.P. Flavin, L.T. Ho, and K. Coughlin Neurotoxicity of soluble macrophage products in vitro influence of dexamethasone Exp. Neurol. 145 1997 462 470
44. M. Galignana, G. Piwien-Pilipuk, and J. Assreuy Inhibition of glucocorticoid receptor binding by nitric oxide Mol. Pharmacol. 55 1999 317 323
45. F. Gallo, M.C. Morale, V. Spina-Purrello, C. Tirolo, N. Testa, Z. Farinella, R. Avola, A. Beaudet, and B. Marchetti Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture Synapse 36 2000 233 253
46. F. Gallo, M.C. Morale, C. Tirolo, N. Testa, Z. Farinella, R. Avola, A. Beaudet, and B. Marchetti Basic fibroblast growth factor (bFGF) priming increases the response of LHRH neurons to neurotrophic factors J. Neuroendocrinol. 12 2000 941 959
47. H.M. Gao, J. Jiang, B. Wilson, W. Zhang, and B. Liu Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease J. Neurochem. 81 2002 1285 1297
48. H.M. Gao, B. Liu, W. Zhang, and J.S. Hong Novel anti-inflammatory therapy for Parkinson's disease Trends Pharmacol. Sci. 24 2003 395 401 (Rev.)
49. H.M. Gao, J.S. Hong, W. Zhang, and B. Liu Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease J. Neurosci. 23 2003 1228 1236
50. M.E. Gegg, B. Beltran, S. Salas-Pino, J.P. Bolanos, J.B. Clark, S. Moncada, and J.R. Heales Differential effect of nitric oxide on glutathione metabolism and mitochondrial function of astrocytes and neurones: implications for neuroprotection/neurodegeneration? J. Neurochem. 86 2003 228 237
51. F. Gennuso, C. Fernetti, C. Tirolo, N. Testa, F. L'Episcopo, S. Caniglia, M.C. Morale, J.D. Ostrow, L. Pascolo, C. Tiribelli, and B. Marchetti Bilirubin protects astrocytes from its own toxicity inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp 1) Proc. Natl. Acad. Sci. U. S. A. 101 2004 2470 2475
52. S. Golde, A. Coles, J.A. Lindqist, and A. Compston Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro Eur. J. Neurosci. 18 2003 2527 2537
53. A.G. Groognan, A.D. Crockard, S. McMillan, and S.A. Hawins Effects of intravenous methylprednisone therapy on leukocyte and soluble adhesion molecule expression in MS Neurology 50 1998 224 230
54. C. Hama, C. Hara, K. Yamaguchi, and A. Miyawaki PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes Neuron 41 2004 405 415
55. C.H. Hay, and J.S. Belleroche Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following intraplantar FCA in parallel with inhibition of oedema Neuropharmacology 6 1998 739 744
56. Y. He, S. Appel, and W. Le Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum Brain Res. 909 2001 187 193
57. A.J. Herrera, A. Castano, J.L. Venero, J. Cano, and A. Machado The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on opaminergic system Neurobiol. Dis. 7 2000 429 447
58. E.C. Hirsch, S. Hunot, P. Damier, and B. Faucheux Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Beyond the decade of the brain: neuroprotection in Parkinson's disease vol. 3 1998 Wells Medical Ltd 227 237
59. A. Ho, and M. Blum Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease J. Neurosci. 18 1998 5614 5629
60. S.M. Hunot, and E.C. Hirsch Neuroinflammatory processes in Parkinson's disease Ann. Neurol. 53 2003 S49 S60
61. S. Hunot, N. Dugas, B. Faucheux, A. Hartmann, M. Tardieu, P. Debre, Y. Agid, B. Dugas, and E.C. Hirsch FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells J. Neurosci. 19 1999 3440 3447
62. M.M. Iravani, K. Kashefi, P. Mander, S. Rose, and P. Jenner Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration Neuroscience 110 2002 49 58
63. K. Ito, S. Lim, G. Caramori, K.F. Chung, P.J. Barnes, and I.M. Adcock Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages FASEB J. 15 2001 1110 1112
64. J.A. Javitch, R.J. D'Amato, S.M. Strittmatter, and S.H. Snyder Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proc. Natl. Acad. Sci. U. S. A. 82 1985 2173 2177
65. B.D. Jenkins, C.B. Pullen, and B.D. Darimont Novel glucocorticoid receptor coactivator effector mechanisms Trends Endocrinol. Metab. 12 2001 122 126
66. P. Jenner Oxidative stress in Parkinson's disease Ann. Neurol. 53 2003 S26 S38
67. P. Jenner, and C.W. Olanow Oxidative stress and the pathogenesis of Parkinson's disease Neurology 47 1996 S161 S170
68. R. Kiefer, and G.W. Kreutzberg Effects of dexamethasone on microglial activation in vivo: selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus J. Neuroimmunol. 34 1991 99 108
69. A. Klegeris, and P.L. McGeer Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity Neurobiol. Aging 23 2002 787 794
70. H. Kleinert, C. Euchenhofer, I. Ihrig-Biedert, and U. Forsterman Glucocorticoids inhibit the induction of nitric oxide II by down-regulating cytokine-induced activity of transcription factor nuclear-factor kappa B. Mol. Pharmacol. 49 1996 15 21
71. R.G. Knowles, M. Salter, S.L. Brooks, and S. Moncada Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat Biochem. Biophys. Res. Commun. 172 1990 1042 1048
72. J. Koistinaho, J. Yrjanheikki, T. Kauppinen, and M. Koistinaho Tetracycline derivatives as anti-inflammatory agents and potential agents in stroke treatment Ernst Schering Res. Found. Workshop 47 2004 101 115
73. R. Korhonen, A. Lahti, M. Hamalainen, H. Kankaanranta, and E. Moilanen Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages Mol. Pharmacol. 62 2002 698 704
74. I. Kurkowska-Jastrzebska, A. Wronska, M. Kohutnicka, A. Czlonkowski, and A. Czlonkowska The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse Exp. Neurol. 156 1999 50 61
75. J.W. Langston, L.S. Forno, J. Tetrud, A.G. Reevers, J.A. Kaplan, and D. Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann. Neurol. 46 1999 598 605
76. M. Lasa, M. Brook, J. Sakalatvala, and A.R. Clark Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38 Mol. Cell. Biol. 21 2001 771 780
77. S. Lehnardt, L. Massillon, P. Follet, F.E. Jensen, R. Rata, P.A. Rosenberg, J.J. Volpe, and T. Vartanian Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc. Natl. Acad. Sci. U. S. A. 100 2003 8514 8519
78. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat. Med. 5 1999 1403 1409
79. C.M. Liberto, P.J. Albrecht, L.M. Herx, V.W. Wong, and S.W. Levinson Pro-regenerative properties of cytokine-activated astrocytes J. Neurochem. 89 2004 1092 1100
80. B. Liu, and J.S. Hong Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention J. Pharmacol. Exp. Ther. 304 2003 1 7 (Rev.)
81. B. Liu, J.W. Jiang, B.C. Wilson, L. Du, S.N. Yang, J.Y. Wang, G.C. Wu, X.D. Cao, and J.S. Hong Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide J. Pharmacol. Exp. Ther. 295 2000 125 132
82. J.B. Long, and J.W. Holaday Blood-brain barrier: endogenous modulation by adrenal cortical function Science 227 1985 1580 1583
83. A.J. Loughlin, M.N. Woodrofe, and M.L. Cruzner Modulation of interior-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids Immunology 79 1993 125 130
84. M. Matsumura, H. Kakishita, M. Suzuki, N. Banba, and Y. Hattori Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells Life Sci. 69 2001 1067 1077
85. B.S. Mc Ewen Protective and damaging affects of stress mediators N. Engl. J. Med. 238 1998 171 179
86. B.S. McEwen, J.M. Weiss, and L.S. Schwartz Selective retention of corticosterone by limbic structures in rat brain Nature 220 1968 911 912
87. B.S. Mc Ewen, C.A. Biron, K.W. Brunson, K. Bulloch, W.H. Chambers, F.S. Dhabar, R.H. Goldfarb, R.P. Kitson, A.H. Miller, R.L. Spencer, and J.M. Weiss The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions Brain Res. Rev. 23 1997 79 133
88. E.G. McGeer, and P.L. McGeer Neurodegeneration and the immune system Neurodegeneration 1995 Academic Press New York 325 337
89. P.L. McGeer, S. Itagaki, B.E. Boyes, and E.G. McGeer Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
90. K.S.P. McNaught, and P. Jenner Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures J. Neurochem. 73 1999 2469
91. K.S.P. McNaught, and P. Jenner Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation Biochem. Pharm. 60 2000 979 988
92. B. Marchetti The LHRH-astroglial network of signals as a model to study neuroimmune interactions: assessment of messenger systems and transduction mechanisms at cellular and molecular levels NeuroimmunoModulation 3 1996 1 27
93. B. Marchetti Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH) neuron-astroglia interactive network Trends Biosci. 2 1997 1 32
94. B. Marchetti, A. Peiffer, M.C. Morale, N. Batticane, and N. Barden Transgenic animals with impaired type II glucocorticoid receptor expression: a model to study aging of the neuroendocrine-immune system Ann. N.Y. Acad. Sci. 719 1994 308 327
95. B. Marchetti, M.C. Morale, N. Testa, C. Tirolo, S. Caniglia, S. Amor, C.D. Dijkstra, and N. Barden Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA Brain Res. Rev. 36 2001 259 272
96. B. Marchetti, M.C. Morale, J. Brouwer, C. Tirolo, N. Testa, S. Caniglia, N. Barden, S. Amor, P.A. Smith, and C.D. Dijkstra Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental allergic encephalomyelitis via nitric oxide-induced immunosuppression J. Immunol. 168 2002 5848 5859
97. D. Mason Genetic variation in the stress response: susceptibility to experimental and implications for human inflammatory disease Immunol. Today 12 1991 57 60
98. M.J. Meaney, S. Bhatnagar, J. Diorio, S. Larocque, D. Francis, D. O'Donnell, N. Shanks, S. Sharma, J. Smythe, and V. Viau Basis for the development of individual differences in the hypothalamic-pituitary-adrenal stress response Cell. Mol. Neurobiol. 13 4 1993 (Aug) 321 347
99. M.J. Meaney, J. Diorio, D. Francis, J. Widdowson, P. La Plante, C. Caldji, S. Sharma, J.R. Seckl, and P.M. Plotsky Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for the adrenocortical response to stress Dev. Neurosci. 18 1996 49 72
100. R.M. Miller, L.M. Callahan, C. Casaceli, L. Chen, G.L. Kiser, B. Chui, T.M. Kaysser-Kranich, T.J. Sendera, C. Palaniappan, and H.J. Federoff Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned mouse substantia nigra J. Neurosci. 24 2004 7445 7454
101. L. Minghetti, and G. Levi Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide Prog. Neurobiol. 54 1998 99 125
102. L. Minghetti, A. Nicolini, E. Polazzi, A. Greco, M. Perretti, L. Parente, and G. Levi Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1 Br. J. Pharmacol. 126 1999 1307 1314
103. M.L. Monje, H. Toda, and T.D. Palmer Inflammatory blockade restores adult hippocampal neurogenesis Science 302 2003 1760 1765
104. M.C. Morale, N. Batticane, F. Gallo, N. Barden, and B. Marchetti Disruption of hypothalamic-pituitary adrenocortical system in transgenic animals expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: effects on T-cell trafficking and T cell responsiveness during postnatal development Endocrinology 136 1995 3949 3960
105. M.C. Morale, F. Gallo, N. Testa, S. Canigli, N. Marletta, V. Spina-Purrello, R. Avola, F. Caucci, P. Tomasi, G. Delitala, N. Barden, and B. Marchetti Special feature: neuroendocrine-immune (NEI) circuitry from neuron-glial interactions to function: focus on gender and HPA-HPG interactions on early programming of the NEI system Immunol. Cell Biol. 79 2001 400 417
106. M.C. Morale, P.A. Serra, M.R. Delogu, R. Migheli, G. Rocchitta, C. Tirolo, S. Caniglia, F. L'Episcopo, F. Gennuso, G.M. Scoto, N. Barden, E. Miele, M.S. Desole, and B. Marchetti Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide FASEB J. 18 1 2004 164 166 [Electronic publication 2003 Nov 20]
107. S. Nadeau, and S. Rivest Glucocorticoids play a fundamental role in protecting the brain during innate immune response J. Neurosci. 23 2003 5536 5644
108. N.R. Nichols Glial responses to steroids as markers of brain aging J. Neurobiol. 40 1999 485 601
109. N.R. Nichols, H.H. Osterburg, J.N. Masters, S.L. Millar, and C.E. Finch Messenger RNA for glia fibrillary acidic protein is decreased in the rat brain following acute and chronic corticosterone treatment Mol. Brain Res. 7 1990 1 7
110. R.N. Nichols, M. Zieba, and N. Bye Do glucocorticoids contribute to brain aging? Brain Res. Rev. 37 2001 273 284
111. C.W. Olanov, A.H.V. Shapira, and Y. Agid Neurodegeneration and prospects for neuroprotection and rescue in Parkinson's disease Ann. Neurol. 53 Suppl. 3 2003 1 170
112. L.C. Park, H. Zhang, and G.E. Gibson Co-culture with astrocytes or microglia protects metabolically impaired neurons Mech. Ageing Dev. 123 2001 21 27
113. S.U. Park, J.V. Ferrer, J.A. Javitch, and D.M. Kuhn Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons J. Neurosci. 22 2002 4399 4405
114. E. Paxinou, Q. Chen, M. Weisse, B.I. Giasson, E.H. Norris, S.M. Rueter, J.Q. Trojanowski, V.M.-Y. Lee, and H. Ishiropoulos Induction of a-synuclein aggregation by intracellular nitrative insult J. Neurosci. 21 2001 8053 8061
115. S. Pennathur, V. Jackson-Lewis, S. Przedborski, and J.W. Heinecke Mass spectrometic quantification of 3-nitrotyrosine, ortho-tyrosine and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydro- pyridine-treated mice, a model of oxidative stress in Parkinson's disease J. Biol. Chem. 274 1999 34621 34628
116. M.C. Pépin, F. Pothier, and N. Barden Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene Nature 355 1992 725 728
117. H. Possel, H. Noack, G. Keilhoff, and G. Wolf Life Imaging of peroxynitrite in rat microglial and astroglial cells: role of superoxide and antioxidants Glia 38 2002 339 350
118. J.M.H.M. Reul, and E.R. DeKloet Two receptor systems for corticosterone in the rat brain: microdistribution and differential occupation Endocrinology 117 1985 2505 2511
119. M.E. Rice Ascorbate regulation and its neuroprotective role in the brain Trends Neurosci. 23 2000 209 219
120. R. Sacedon, A. Vicente, A. Varas, M.C. Morale, N. Barden, B. Marchetti, and A. Zapata Partial blockade of T-cell differentiation and marked alteration of the thymic microenvironment in transgenic mice with a dysfunctional glucocorticoid receptor function J. Neuroimmunol. 98 1999 157 167
121. K. Sairam, K.S. Saravanan, R. Banerjee, and K.P. Mohanakumar Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats Brain Res. 966 2003 245 252
122. R.M. Sapolsky, L.M. Romero, and A.U. Munck How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocr. Rev. 21 2000 55 89
123. P.A. Serra, L. Sciola, M.R. DeLogu, A. Spano, G. Monaco, E. Miele, G. Rocchitta, R. Migheli, and M.S. Desole The neurotoxin MPTP induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes J. Biol. Chem. 277 2002 34451 34461
124. N. Shanks, S. Larocque, and M. Meaney Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary adrenal axis: early illness and later responsivity to stress J. Neurosci. 15 1995 376 384
125. N. Shanks, R.J. Windle, M.S. Harbuz, D.S. Jessop, C. Ingram, and S.M. Lightman Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation Proc. Natl. Acad. Sci. 97 2000 5645 5650
126. R.I. Scheinman, P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids Science 270 5234 1995 283 286 (Oct. 13)
127. C.Y. Shin, J.I.W. Choi, J.R. Ko, K.H. Ryu, J.J. Choi, H.S. Kim, H.S. Kim, J.C. Lee, S.J. Lee, H.C. Kim, and W.K. Kim Glucose deprivation decreases nitric oxide production via NADPH depletion in immunostimulated rat primary astrocytes Glia 37 2002 268 274
128. S.S. Simons, and W.B. Pratt Glucocorticoid receptor thiols and steroid-binding activity Methods Enzymol. 251 1995 406 422
129. M. Smeyne, O. Goloubeva, and R.J. Smeyne Strain-dependent susceptibility to MPTP and MPTP(+)-induced parkinsonism is determined by glia Glia 34 2001 73 80
130. K. Sriram, J.M. Matheson, S.A. Benkovic, D.B. Miller, M.I. Luster, and J.P. O'Callaghan Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease FASEB J. 16 2002 1474 1476
131. I. Stec, N. Barden, J.M.H. M Reul, and F. Holsboer Dexamethasone non-suppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor J. Psychiatr. Res. 28 1993 1 5
132. W.J. Streit, Neuroinflammation-from Bench to Bedside, H. Ketteenman, G.A. Burton, U.J. Moenning, (Eds), Springer, Berlin pp. 11-24.
133. W.J. Streit Physiology and pathophysiology of microglial cell function W.J. Streit Microglia in the regenerating and degenerating central nervous system 2002 Springer 1 15
134. W.J. Streit Microglia as neuroprotective, immunocompetent cells of the CNS Glia 40 2002 133 139
135. T. Takeshima, J.M. Johnston, and J.W. Commissiong Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation J. Neurosci. 14 1994 4769 4779
136. P. Teismann, M. Vila, D.K. Choi, K. Tieu, D.C. Wu, V. Jackson-Lewis, and S. Przedborski COX-2 and neurodegeneration in Parkinson's disease Ann. N.Y. Acad. Sci. 991 2003 272 277 (Review)
137. M. Vila, V. Jackson-Lewis, C. Guegan, D.C. Wu, P. Teismann, D.K. Chon, K. Tieu, and S. Przedborski The role of glial cells in Parkinson's disease Curr. Opin. Neurol. 14 2001 483 489 (Rev.)
138. V. Viswanath, T. Wu, R. Boonplueang, S. Chen, F.F. Stevenson, F. Yantiri, L. Yang, M.F. Beal, and J.K. Andersen Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease J. Neurosci. 21 2001 9519 9528
139. T.T. Warner, and A.H.V. Schapira Genetic and environmental factors in the cause of Parkinson's disease Ann. Neurol. 53 2003 S16 S25
140. J.C. Webster, R.H. Oakley, C.M. Jewel, and J.A. Cidlowski Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance Proc. Natl. Acad. Sci. U. S. A. 98 2001 6865 6870
141. D.O. Willenborg, M.A. Staykova, and W.B. Cowden Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review J. Neuroimmunol. 100 1999 21 35
142. C.C. Winterbourn, and D. Metodiewa Reaction of superoxide with glutathione and other thiols Methods Enzymol. 251 1995 81 86
143. S.D. Wright Toll, a new piece in the puzzle of innate immunity J. Exp. Med. 189 1999 605 609
144. S. Wust, E.F.C. van Rossum, I.S. Federenko, J.W. Koper, R. Kumsta, and D.H. Hellhammer Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress J. Clin. Endocrinol. Metab. 89 2004 565 573
145. T. Wyss-Coray, and L. Micke Inflammation in neurodegenerative disease-a double-edged sword Neuron 35 2002 419 432 (Rev.)